Common Indications for Referral to the Healthcare system for COVID-19 recovered patients versus Qatar Biobank study population: A descriptive analysis

Common Indications for Referral to the Healthcare system for COVID-19 recovered patients versus Qatar Biobank study population: A descriptive analysis

Authors

  • Marwa Eldeeb
  • Eleni Fthenou
  • Noha Elkousy
  • Nadia Sheikh
  • Mustafa Nasr
  • Nahal Afifi
  • Asma Al Thani
  • Michael Frenneaux

Keywords:

COVID 19, Reason for referrals, Diabetes, Qatar biobank

Abstract

Background and Aim of the Work:

Qatar Biobank (QBB) is actively acquiring data on the range of short- and long-term health impacts associated with COVID-19. This is performed through the COVID-19 biorepository National project. In this report, we describe the most common indications for the referral to Qatar’s healthcare system of COVID-19 biorepository participants in comparison with the Qatar Biobank (QBB) general population study.

Methods

Patients with a laboratory diagnosis of COVID-19, who were Qatar residents that could communicate in Arabic, English, Hindi and Urdu were eligible to participate in the COVID-19 biorepository project. Biological samples of Consented participants were collected on a weekly basis until recovery, and then monthly for a year. Participants were also offered a bone density scan three months after recovery and non-contrast MRI brain and whole-body scan six months after recovery. Number of participants requiring referral for medical follow up after recovery for any abnormal clinically significant findings were recorded and statistically compared to general population referred participants

Results:

The majority of referrals for the general population study was for osteopenia versus diabetes for the COVID-19 biorepository project

Conclusion

Descriptive analysis of the referral data of the COVID-19 participants and QBB general population (not previously affected by the virus) shows a clear difference between the two populations’ reasons for referrals. Diabetes for COVID 19 recovered participants versus osteopenia for general population

Keywords:

COVID19, Reason for Referrals, Diabetes, Qatar biobank

 

 

References

- Awadhesh Kumar Singh,Ritesh Gupta,Amerta Ghosh and Anoop Misra. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020 July-August; 14(4): 303–310

- Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in wuhan, China, JAMA Intern Med. 2020 Jul; 180(7): 1–11

- Konstantinos Michalakis and Ioannis Ilias. COVID-19 and hyperglycemia/diabetes. World J Diabetes. 2021 May 15;12(5):642-650.

- Singh AK, Singh R. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19. Diabetes Res Clin Pract. 2020 Sep;167:108382

Downloads

Published

14-03-2022

Issue

Section

ORIGINAL INVESTIGATIONS/COMMENTARIES - SPECIAL COVID19

How to Cite

1.
Eldeeb M, Fthenou E, Elkousy N, Sheikh N, Nasr M, Afifi N, et al. Common Indications for Referral to the Healthcare system for COVID-19 recovered patients versus Qatar Biobank study population: A descriptive analysis. Acta Biomed [Internet]. 2022 Mar. 14 [cited 2024 Jul. 21];93(1):e2022033. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/11887